Results 81 to 90 of about 21,294 (218)

First-in-human, open-label dose-escalation and dose-expansion study of the safety, pharmacokinetics, and antitumor effects of an oral ALK inhibitor ASP3026 in patients with advanced solid tumors [PDF]

open access: yes, 2016
Background ASP3026 is a second-generation anaplastic lymphoma kinase (ALK) inhibitor that has potent in vitro activity against crizotinib-resistant ALK-positive tumors.
Anthony Tolcher   +8 more
core   +3 more sources

Success of Crizotinib Combined with Whole-Brain Radiotherapy for Brain Metastases in a Patient with Anaplastic Lymphoma Kinase Rearrangement-Positive Non-Small-Cell Lung Cancer

open access: yesCase Reports in Oncology, 2018
Although crizotinib shows marked antitumor activity in anaplastic lymphoma kinase (ALK) rearrangement-positive non-small-cell lung cancer (NSCLC) patients, all treated patients ultimately develop resistance to this drug.
Sachi Okawa   +12 more
doaj   +1 more source

Phytochemical‐Based Strategies for Lung Cancer: Clinical Insights Into Pleiotropic Molecular Signaling and Therapeutic Roles

open access: yesPhytotherapy Research, EarlyView.
Lung cancer (LC) remains the leading cause of global cancer‐related death. Phytochemicals from medicinal plants are increasingly being considered as potential LC treatment agents due to their multi‐targeted action, safety, and accessibility. These have anticancer properties by regulating key molecular signaling pathways.
Md. Rezaul Islam   +14 more
wiley   +1 more source

Mycosis Fungoides Is a Proliferation of Multiple Mutational Subclones

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Mycosis fungoides (MF) is a unique type of lymphoma with an excellent prognosis presenting with a wide variety of clinical and histological findings. Recent sophisticated research techniques have revealed that very slow changes in the clinical and histological pictures of one patient over time are due to intratumoral heterogeneity.
Ryoma Honda   +2 more
wiley   +1 more source

A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer. [PDF]

open access: yes, 2012
Metastatic non-small cell lung cancer (NSCLC) carries a dismal prognosis. Clinical evidence suggests the existence of an intermediate, or oligometastatic, state when metastases are limited in number and/or location.
Niibe, Yuzuru   +4 more
core   +3 more sources

Small cell lung cancer with EML4-ALK fusion: report of a case responding to ALK TKI and literature review

open access: yesJournal of Cancer Research and Clinical Oncology
Purpose With the continuous development and progress of next-generation gene sequencing technology, many types of anaplastic lymphoma kinase (ALK) rearrangement have been discovered.
Mingyue Wang   +6 more
doaj   +1 more source

ALK-Positive Squamous Cell Carcinoma Dramatically Responded to Alectinib

open access: yesCase Reports in Oncological Medicine, 2018
Anaplastic lymphoma kinase (ALK) rearrangement is usually observed in patients with adenocarcinoma. Herein, we report a case of squamous cell carcinoma (SCC) with ALK rearrangement treated with alectinib.
Ray Sagawa   +3 more
doaj   +1 more source

ALK-rearranged renal cell carcinomas in Polish population

open access: yesPathology - Research and Practice, 2019
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase, the activation of which is considered an important event in the pathogenesis of several neoplasms and a predictive factor for the targeted therapy with ALK inhibitors. Thus far, ALK rearrangements have been identified in 22 renal cell carcinomas in both pediatric and adult patients.
Adam, Gorczynski   +6 more
openaire   +4 more sources

Sequence of Immunological Events During IgE‐Mediated Allergic Reactions to Food

open access: yesAllergy, EarlyView.
ABSTRACT Food allergies (FA) represent a significant global health burden. Upon allergen re‐exposure, allergic patients exhibit a sequence of symptoms that vary in terms of affected organ systems, severity, time of onset and allergen reactivity thresholds.
N. A. Nagy   +7 more
wiley   +1 more source

Nichtkleinzellige Lungenkarzinome: Subklassifikation und prädiktive molekulare Markeruntersuchungen in der Zytologie [PDF]

open access: yes, 2018
Zusammenfassung: In der Lungenkarzinomdiagnostik haben sich die Anforderungen an die Zytologie in den letzen Jahren deutlich verändert. Eine exakte Subtypisierung nichtkleinzelliger Lungenkarzinome (NSCLC) in Adeno- und Plattenepithelkarzinome ...
Bihl, M.P., Bubendorf, L., Savic, S.
core  

Home - About - Disclaimer - Privacy